1Bonnel A R, Bunchorntavakul C, Reddy K R. Immunedysfunction and infections in patients with cirrhosis [ J ].Clin Gastroenterol Hepatol, 2011 ,9(9) :727-738.
2Shirai S, Sato M , Suwa K, et al. Single photon emissioncomputed tomography-based three-dimensional conformalradiotherapy forhepatocellular carcinoma with portal veintumor thrombus [ J ]. Int J Radiat Oncol Biol Phys, 2009 ,73(3) :824-831.
3Ahn C Y, Bae S K, Jung Y S, ei al. Pharmacokinetic pa-rameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administra-tion of chlorzoxazone to liver cirrhotic rats with diabetes mel-litus[J].Drug Metab Dispos, 2008,36(7) :1233-1241.
4Tulloch L,Rukin N J, Creamer J. Diabetes and a largeliver[J]. Lancet, 2007,370(9591) :1006.
